Sarepta Therapeutics, Inc. financial data

Symbol
SRPT on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
02 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 292% % -27%
Quick Ratio 111% % 39%
Debt-to-equity 182% % -7.6%
Return On Equity -58% % -393%
Return On Assets -20% % -408%
Operating Margin -32% % -378%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 104,989,772 shares 6.8%
Common Stock, Shares, Outstanding 104,964,220 shares 8.3%
Entity Public Float $1,670,773,865 USD
Common Stock, Value, Issued $11,000 USD 10%
Weighted Average Number of Shares Outstanding, Basic 100,120,000 shares 5.3%
Weighted Average Number of Shares Outstanding, Diluted 100,120,000 shares -7.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $2,198,237,000 USD 16%
Revenue from Contract with Customer, Excluding Assessed Tax $1,864,296,000 USD 4.3%
Costs and Expenses $2,898,018,000 USD 72%
Operating Income (Loss) $699,781,000 USD -421%
Nonoperating Income (Expense) $2,444,000 USD -106%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $702,225,000 USD -369%
Income Tax Expense (Benefit) $11,185,000 USD -56%
Net Income (Loss) Attributable to Parent $713,410,000 USD -403%
Earnings Per Share, Basic -7.02 USD/shares -387%
Earnings Per Share, Diluted -7.14 USD/shares -413%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $801,282,000 USD -27%
Accounts Receivable, after Allowance for Credit Loss, Current $398,233,000 USD -34%
Inventory, Net $914,744,000 USD 22%
Other Assets, Current $171,856,000 USD 90%
Assets, Current $2,537,938,000 USD -17%
Property, Plant and Equipment, Net $345,125,000 USD 1.4%
Operating Lease, Right-of-Use Asset $125,495,000 USD -15%
Other Assets, Noncurrent $155,554,000 USD 95%
Assets $3,349,703,000 USD -15%
Accounts Payable, Current $280,841,000 USD 31%
Employee-related Liabilities, Current $58,607,000 USD -36%
Accrued Liabilities, Current $359,659,000 USD -3.7%
Contract with Customer, Liability, Current $443,397,000 USD 240%
Liabilities, Current $1,095,290,000 USD 50%
Contract with Customer, Liability, Noncurrent $83,910,000 USD -74%
Operating Lease, Liability, Noncurrent $199,378,000 USD 3.6%
Other Liabilities, Noncurrent $1,529,000 USD -13%
Liabilities $2,209,081,000 USD -9.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax $272,000 USD
Retained Earnings (Accumulated Deficit) $4,876,984,000 USD -16%
Stockholders' Equity Attributable to Parent $1,140,622,000 USD -25%
Liabilities and Equity $3,349,703,000 USD -15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $583,437,000 USD -141%
Net Cash Provided by (Used in) Financing Activities $12,471,000 USD -44%
Net Cash Provided by (Used in) Investing Activities $291,177,000 USD -233%
Common Stock, Shares Authorized 198,000,000 shares 0%
Common Stock, Shares, Issued 105,615,096 shares 9%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $862,143,000 USD -75527%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $814,407,000 USD -27%
Interest Paid, Excluding Capitalized Interest, Operating Activities $7,188,000 USD 0%
Deferred Tax Assets, Valuation Allowance $1,106,930,000 USD 25%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross $1,140,091,000 USD 24%
Operating Lease, Liability $210,574,000 USD 2.3%
Payments to Acquire Property, Plant, and Equipment $43,651,000 USD 35%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $712,920,000 USD -405%
Lessee, Operating Lease, Liability, to be Paid $340,315,000 USD -11%
Property, Plant and Equipment, Gross $626,040,000 USD 9%
Operating Lease, Liability, Current $11,196,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year Two $25,599,000 USD -19%
Lessee, Operating Lease, Liability, to be Paid, Year One $27,774,000 USD -13%
Operating Lease, Weighted Average Discount Rate, Percent 0.079 pure -1.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $129,741,000 USD -27%
Lessee, Operating Lease, Liability, to be Paid, Year Three $26,336,000 USD -17%
Deferred Tax Assets, Operating Loss Carryforwards $96,587,000 USD 43%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3,333,333 shares 0%
Unrecognized Tax Benefits $67,950,000 USD 2.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four $26,336,000 USD -18%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $2,622,000 USD 9%
Depreciation, Depletion and Amortization $9,978,000 USD 14%
Share-based Payment Arrangement, Expense $14,900,000 USD -66%
Interest Expense $38,140,000 USD -107%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%